Annual SG&A
$258.69M$124.29M+92.48%
Summary
- Current Value
- As of today, ARDX annual SG&A is $258.69M, up +92.48% on
- Historical Performance
- ARDX annual SG&A is up +257.79% over the past 3 years, and up +966.02% over the past 5 years
- All-Time High Comparison
- ARDX annual SG&A is currently at its all-time high
- 3-Year Low Comparison
- ARDX annual SG&A is +237.72% above its 3-year low of $76.60M reached on an earlier date
- Sector Comparison
- ARDX annual SG&A is higher than 91.01% of companies in Healthcare sector
SG&A Chart
Add series to chart1/6
Series
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual SG&A | $258.69M | +92.5% | +257.8% | +966.0% | +6317.6% | |
| Quarterly SG&A | $83.61M | +28.7% | +347.9% | +995.3% | +8041.4% | |
| TTM SG&A | -$3.70B | -1707.8% | -5229.9% | -10000.0% | -10000.0% | |
| Price | $7.94 | +44.0% | +149.5% | +9.9% | – | |
| Annual Operating Expenses | $311.01M | +83.0% | +90.3% | +224.2% | +2087.9% | |
| Annual Operating Profit | -$27.95M | +55.8% | +81.9% | +69.4% | -217.4% | |
| Annual D&A | $2.06M | +59.7% | -26.5% | -17.5% | +205.6% | |
| Annual Revenue | $333.62M | +168.1% | +3204.1% | +6217.3% | +6066.6% |
SG&A Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $258.69M | at high | |
| 5Y | $258.69M | at high | |
| All | $258.69M | at high |
SG&A Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $76.60M | N/A | +237.7% |
| 5Y | $33.15M | N/A | +680.3% |
| All | $3.70M | +6891.7% |
SG&A History
FAQ
What is the current annual SG&A of ARDX?
As of today, ARDX annual SG&A is $258.69M
What is 1-year change in ARDX annual SG&A?
ARDX annual SG&A is up +92.48% year-over-year
What is 3-year change in ARDX annual SG&A?
ARDX annual SG&A is up +257.79% over the past 3 years
How far is ARDX annual SG&A from its all-time high?
ARDX annual SG&A is currently at its all-time high
How does ARDX annual SG&A rank versus sector peers?
ARDX annual SG&A is higher than 91.01% of companies in Healthcare sector
When is ARDX next annual earnings release?
The next annual earnings release for ARDX is on
Quarterly SG&A
$83.61M$376.00K-0.45%
Summary
- Current Value
- As of today, ARDX quarterly SG&A is $83.61M, down -0.45% on
- Historical Performance
- ARDX quarterly SG&A is up +28.69% year-over-year, and up +347.91% over the past 3 years
- All-Time High Comparison
- ARDX quarterly SG&A is currently -0.45% below its historical high of $83.99M set on
- 3-Year Low Comparison
- ARDX quarterly SG&A is +323.76% above its 3-year low of $19.73M reached on an earlier date
- Sector Comparison
- ARDX quarterly SG&A is higher than 90.25% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly SG&A | $83.61M | -0.5% | +28.7% | +347.9% | +995.3% | |
| Annual SG&A | $258.69M | – | +92.5% | +257.8% | +966.0% | |
| TTM SG&A | -$3.70B | -1301.6% | -1707.8% | -5229.9% | -10000.0% | |
| Price | $7.94 | +56.8% | +44.0% | +149.5% | +9.9% | |
| Quarterly Operating Expenses | $100.77M | +1.8% | +26.4% | +309.1% | +487.2% | |
| Quarterly Operating Profit | $4.67M | +132.4% | +109.0% | +121.3% | +127.2% | |
| Quarterly D&A | $905.00K | +43.4% | +66.4% | -39.7% | -7.8% | |
| Quarterly Revenue | $110.33M | +13.0% | +12.3% | +2112.8% | +3966.7% |
Quarterly SG&A Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $83.99M | -0.5% | |
| 3Y | $83.99M | -0.5% | |
| 5Y | $83.99M | -0.5% | |
| All | $83.99M | -0.5% |
Quarterly SG&A Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $76.07M | N/A | +9.9% |
| 3Y | $19.73M | N/A | +323.8% |
| 5Y | $11.34M | N/A | +637.1% |
| All | $1.03M | +8041.4% |
Quarterly SG&A History
FAQ
What is the current quarterly SG&A of ARDX?
As of today, ARDX quarterly SG&A is $83.61M
What is ARDX quarterly SG&A most recent change?
ARDX quarterly SG&A was down -0.45% on September 30, 2025
What is 1-year change in ARDX quarterly SG&A?
ARDX quarterly SG&A is up +28.69% year-over-year
How far is ARDX quarterly SG&A from its all-time high?
ARDX quarterly SG&A is currently -0.45% below its historical high of $83.99M set on June 30, 2025
How does ARDX quarterly SG&A rank versus sector peers?
ARDX quarterly SG&A is higher than 90.25% of companies in Healthcare sector
When is ARDX next earnings release?
The next earnings release for ARDX is on
TTM SG&A
-$3.70B$56.55M-1.55%
Summary
- Current Value
- As of today, ARDX TTM SG&A is -$3.70B, down -1.55% on
- Historical Performance
- ARDX TTM SG&A is down -1707.84% year-over-year, and down -5229.94% over the past 3 years
- All-Time High Comparison
- ARDX TTM SG&A is currently -5295.13% below its historical high of -$68.65M set on an earlier date
- 3-Year Low Comparison
- ARDX TTM SG&A is at its 3-year low
- Sector Comparison
- ARDX TTM SG&A is higher than 14.10% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM SG&A | -$3.70B | -1301.6% | -1707.8% | -5229.9% | -10000.0% | |
| Annual SG&A | $258.69M | – | +92.5% | +257.8% | +966.0% | |
| Quarterly SG&A | $83.61M | -0.5% | +28.7% | +347.9% | +995.3% | |
| Price | $7.94 | +56.8% | +44.0% | +149.5% | +9.9% | |
| TTM Operating Profit | -$37.95M | +6.0% | +40.8% | +65.9% | +53.7% | |
| TTM D&A | $2.65M | +15.8% | +440.1% | -42.7% | -50.1% | |
| TTM Revenue | $398.23M | +3.1% | +58.1% | +4320.4% | +4870.5% |
TTM SG&A Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | -$3.54B | N/A | -4.7% |
| 3Y | -$3.08B | N/A | -20.3% |
| 5Y | -$2.07B | N/A | -78.8% |
| All | -$68.65M | N/A | -5295.1% |
TTM SG&A Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | -$3.70B | N/A | at low |
| 3Y | -$3.70B | N/A | at low |
| 5Y | -$3.70B | N/A | at low |
| All | -$3.70B | N/A | at low |
TTM SG&A History
FAQ
What is the current TTM SG&A of ARDX?
As of today, ARDX TTM SG&A is -$3.70B
What is ARDX TTM SG&A most recent change?
ARDX TTM SG&A was down -1.55% on September 30, 2025
What is 1-year change in ARDX TTM SG&A?
ARDX TTM SG&A is down -1707.84% year-over-year
How does ARDX TTM SG&A rank versus sector peers?
ARDX TTM SG&A is higher than 14.10% of companies in Healthcare sector
When is ARDX next earnings release?
The next earnings release for ARDX is on
Selling, General & Administrative Expenses Formula
SG&A = − − R&D
Data Sources & References
- ARDX Official Website www.ardelyx.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1437402/000143740225000018/0001437402-25-000018-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1437402/000162828025006653/0001628280-25-006653-index.htm
- ARDX Profile on Yahoo Finance finance.yahoo.com/quote/ARDX
- ARDX Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/ardx